Literature DB >> 23983438

Prevalence and features of fatty liver detected by physical examination in Guangzhou.

Xian-Hua Liao1, Xu Cao, Jie Liu, Xiao-Hua Xie, Yan-Hong Sun, Bi-Hui Zhong.   

Abstract

AIM: To investigate the prevalence of fatty liver discovered upon physical examination of Chinese patients and determine the associated clinical characteristics.
METHODS: A total of 3433 consecutive patients who received physical examinations at the Huangpu Division of the First Affiliated Hospital at Sun Yat-sen University in Guangzhou, China from June 2010 to December 2010 were retrospectively enrolled in the study. Results of biochemical tests, abdominal ultrasound, electrocardiography, and chest X-ray were collected. The diagnosis of fatty liver was made if a patient met any two of the three following ultrasonic criteria: (1) liver and kidney echo discrepancy and presence of an increased liver echogenicity (bright); (2) unclear intrahepatic duct structure; and (3) liver far field echo decay.
RESULTS: The study population consisted of 2201 males and 1232 females, with a mean age of 37.4 ± 12.8 years. When all 3433 patients were considered, the overall prevalence of hyperlipidemia was 38.1%, of fatty liver was 26.0%, of increased alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) levels was 11.9%, of gallstone was 11.4%, of hyperglycemia was 7.3%, of hypertension was 7.1%, and of hyperuricemia was 6.2%. Of the 2605 patients who completed the abdominal ultrasonography exam, 677 (26.0%) were diagnosed with fatty liver and the prevalence was higher in males (32.5% vs females: 15.3%, P < 0.001). The overall prevalence of fatty liver increased with age, with the peak prevalence (39.5%) found in the 60 to 70-year-old age group. Among patients between the ages of 18 to 50-year-old, the prevalence of fatty liver was significantly higher in males (20.2% vs females: 8.7%, P < 0.001); the difference in prevalence between the two sexes in patients > 50-year-old did not reach statistical significance. Only 430 of the patients diagnosed with fatty liver had complete information; among those, increased ALT and/or AST levels were detected in only 30%, with all disturbances being mild or moderate. In these 430 patients, the overall prevalence of hypertriglyceridemia was 31.4%, of mixed type hyperlipidemia was 20.9%, of hypercholesterolemia was 12.3%, of hyperglycemia was 17.6%, of hypertension was 16.0%, of hyperuricemia was 15.3%, and of gallstone was 14.4%. Again, the prevalences of hypertriglyceridemia and hyperuricemia were higher in males (hypertriglyceridemia, 36.0% vs females: 12.0%, P < 0.05; hyperuricemia, 17.3% vs females: 7.2%, P < 0.05); in contrast, however, the prevalences of mixed type hyperlipidemia and hypercholesterolemia was higher in females (mixed type hyperlipidemia, 18.7% vs females: 30.1%, P < 0.05, hypercholesterolemia, 9.5% vs females: 24.1%, P < 0.05). Finally, comparison of the fatty liver group to the non-fatty liver group showed that prevalences of hyperlipidemia, hyperglycemia, hypertension, and hyperuricemia were higher in the former (all P < 0.01).
CONCLUSION: A high prevalence of fatty liver is detected upon physical examination in Guangzhou, and the primary associated clinical findings are hyperlipidemia, hyperglycemia, hypertension, and hyperuricemia.

Entities:  

Keywords:  Fatty liver; Hyperglycemia; Hyperlipidemia; Hypertension; Nonalcoholic; Prevalence

Mesh:

Substances:

Year:  2013        PMID: 23983438      PMCID: PMC3752569          DOI: 10.3748/wjg.v19.i32.5334

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Anna Mae Diehl; Elizabeth M Brunt; Kenneth Cusi; Michael Charlton; Arun J Sanyal
Journal:  Gastroenterology       Date:  2012-05-15       Impact factor: 22.682

2.  Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition.

Authors:  Fan Jian-gao
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2010-03

3.  [Chinese guidelines on prevention and treatment of dyslipidemia in adults].

Authors: 
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2007-05

Review 4.  Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.

Authors:  G Vernon; A Baranova; Z M Younossi
Journal:  Aliment Pharmacol Ther       Date:  2011-05-30       Impact factor: 8.171

5.  [2010 Chinese guidelines for the management of hypertension].

Authors:  Li-Sheng Liu
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2011-07

6.  Fatty infiltration of liver in hyperlipidemic patients.

Authors:  N Assy; K Kaita; D Mymin; C Levy; B Rosser; G Minuk
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

Review 7.  Metabolic syndrome and risk factors for non-alcoholic fatty liver disease.

Authors:  Mônica Rodrigues de Araújo Souza; Margareth de Fátima Formiga de Melo Diniz; José Eymard Moraes de Medeiros-Filho; Maria Salete Trigueiro de Araújo
Journal:  Arq Gastroenterol       Date:  2012 Jan-Mar

8.  Non-alcoholic fatty liver disease in older people.

Authors:  James Frith; Christopher P Day; Elsbeth Henderson; Alastair D Burt; Julia L Newton
Journal:  Gerontology       Date:  2009-08-19       Impact factor: 5.140

9.  Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease.

Authors:  Zhou-wen Chen; Li-ying Chen; Hong-lei Dai; Jian-hua Chen; Li-zheng Fang
Journal:  J Zhejiang Univ Sci B       Date:  2008-08       Impact factor: 3.066

10.  Prevalence of non-alcoholic fatty liver disease: population based study.

Authors:  Deepak Amarapurkar; Prafull Kamani; Nikhil Patel; Parijat Gupte; Pravin Kumar; Subhash Agal; Rajiv Baijal; Somesh Lala; Dinesh Chaudhary; Anjali Deshpande
Journal:  Ann Hepatol       Date:  2007 Jul-Sep       Impact factor: 2.400

View more
  7 in total

1.  The prevalence and adverse profiles of fatty liver disease among different ethnic public servants in Urumqi of Xinjiang Uygur Autonomous Region in China.

Authors:  Dan Chen; Jie Guan; Xiang Xie; Wei-Yun Zhao; Palida Abulaiti; Yu Wang; Zhi-Qin Cheng; Jing Zhang; Ying Gao
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.

Authors:  Zhen-Ya Lu; Zhou Shao; Ya-Li Li; Muhuyati Wulasihan; Xin-Hua Chen
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

3.  Prevalence of and risk factors for gallstones in Uighur and Han Chinese.

Authors:  Li Zhu; Aikebaier Aili; Cheng Zhang; Aili Saiding; Kelimu Abudureyimu
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

4.  Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.

Authors:  Wei-Dong Li; Kun-Fa Fu; Gui-Mei Li; Yan-Shu Lian; Ai-Min Ren; Yun-Jue Chen; Jin-Rong Xia
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

5.  Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study.

Authors:  Juanwen Zhang; Ying Zhao; Chengfu Xu; Yani Hong; Huanle Lu; Jianping Wu; Yu Chen
Journal:  Sci Rep       Date:  2014-07-25       Impact factor: 4.379

6.  Association of leukocyte telomere length with non-alcoholic fatty liver disease in patients with type 2 diabetes.

Authors:  Min Zhang; Man-Li Hu; Jiao-Jiao Huang; San-Shan Xia; Yan Yang; Kun Dong
Journal:  Chin Med J (Engl)       Date:  2019-12-20       Impact factor: 2.628

7.  Study on the correlation between urinary retinol-binding protein and nonalcoholic fatty liver disease.

Authors:  Chuang Li; Weiwei Kong; Lixia Kang; Tiehan Zhang; Weiqun Zhang; Weidong Wang
Journal:  J Med Biochem       Date:  2021-01-26       Impact factor: 3.402

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.